BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Sean McCarthy will join a roundtable discussion of "How to Transform your Technology into a Sustainable Marketable Product" at the San Jose BioCenter.
News | 03. 22. 2007
